切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - CK1 - Urokinases - c-MET - Progesterone Receptors

16件产品中的 1-10

页面
每页
清除全部
  1. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR抑制剂
      ≥21.55 mg/mL
      insoluble in H2O
  2. Medroxyprogesterone
    B3471 Medroxyprogesterone
    中文名: 甲羟孕酮
    Target: Progesterone Receptors
    Summary: 强效孕酮受体激动剂
      ≥34.4 mg/mL
      insoluble in H2O
  3. Etonogestrel
    B3470 Etonogestrel
    中文名: 依托孕烯
    Target: Progesterone Receptors
    Summary: 甾体孕激素
      ≥15.05 mg/mL
      insoluble in H2O
  4. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  5. Medroxyprogesterone acetate
    B1510 Medroxyprogesterone acetate
    中文名: 醋酸甲羟孕酮
    Target: Progesterone Receptors
    Summary: 类固醇孕激素
      ≥9.48 mg/mL
      insoluble in H2O
  6. Mifepristone
    B1511 Mifepristone
     3 Citation
    中文名: 美服培酮
    Target: Progesterone Receptors|Glucocorticoid Receptors
    Summary: 孕激素受体拮抗剂
      ≥21.48 mg/mL
      insoluble in H2O
  7. INCB28060
    A8448 INCB28060
    中文名: 苯扎米特
    Target: c-MET
    Summary: C-Met抑制剂
      ≥5.15 mg/mL
      insoluble in H2O
  8. MGCD-265
    A5057 MGCD-265
    Target: VEGFR|c-MET
    Summary: Met/Flt/Flk/Ron/Tie-2抑制剂
      ≥25.9 mg/mL
      insoluble in H2O
  9. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: 有效的HER2选择性抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  10. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met的选择性和ATP竞争性抑制剂
      ≥18.6 mg/mL
      insoluble in H2O

16件产品中的 1-10

页面
每页